SCHEMBL2229951

SCHEMBL2229951

C[C@H]1[C@H]2CN(C(=O)[C@@H](NC(=O)c3cc4ccccc4[nH]3)C(C)(C)C)[C@@H]1CN2C(=O)c1ccc(-c2ccccc2)cn1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP51A1 Q16850 1/20 0.39
DRD2 P14416 2/20 0.38
HTR2B P41595 1/20 0.38
STAT6 P42226 1/20 0.38
HRH4 Q9H3N8 1/20 0.37
PYGL P06737 2/20 0.37
CCKBR P32239 4/20 0.36
KDM5A P29375 1/20 0.36
TAS1R3 Q7RTX0 1/20 0.36
TAS1R1 Q7RTX1 1/20 0.36
HSPA5 P11021 1/20 0.36
HSPA8 P11142 1/20 0.36
HSPA9 P38646 1/20 0.36
HSPA2 P54652 1/20 0.36
OPRK1 P41145 1/20 0.35
OPRM1 P35372 1/20 0.35
DRD3 P35462 1/20 0.35
AKR1C3 P42330 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19856859 0.88 CYP51A1 (0.40) CYP51A1DRD2HTR2BSTAT6HRH4
SCHEMBL1549976 0.88 CYP51A1 (0.40) CYP51A1DRD2HTR2BSTAT6HRH4
SCHEMBL1550050 0.88 CYP51A1 (0.40) CYP51A1DRD2HTR2BSTAT6HRH4
SCHEMBL14980536 0.87 HTR2B (0.46) CYP51A1DRD2HTR2BSTAT6HRH4
SCHEMBL6876269 0.86 GHSR (0.44) CYP51A1DRD2HTR2BSTAT6HRH4
SCHEMBL14980460 0.85 STAT6 (0.41) CYP51A1DRD2HTR2BSTAT6CCKBR
SCHEMBL1550049 0.84 DRD2 (0.37) CYP51A1DRD2HTR2BSTAT6HRH4
SCHEMBL12552765 0.83 DRD2 (0.37) CYP51A1DRD2STAT6KDM5AHSPA5
SCHEMBL1550195 0.83 ALOX15 (0.42) CYP51A1STAT6PYGL
SCHEMBL1550758 0.83 NAMPT (0.40) CYP51A1DRD2STAT6HRH4KDM5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011091407-A1 TRPV4 ANTAGONISTS GLAXOSMITHKLINE LLP (US) 2011-07-28 WO claimed
WO-2011091407-A1 TRPV4 ANTAGONISTS GLAXOSMITHKLINE LLP (US) 2011-07-28 WO disclosed